By integrating the results from these four algorithms, we discovered that BCL10 expression was negatively correlated with tumor-suppressing immune cells, including CD8+ T, CD4+ Th1, and NKT cells, and positively correlated with tumor-promoting immune cells, such as CD4+ Th2 and Treg cells (Figure 2, Supplementary Figure 1). The gene discussed is BCL10; the disease is neoplasm.